Lesaka Technologies, Inc. (LSAK)
(Delayed Data from NSDQ)
$4.63 USD
+0.11 (2.50%)
Updated Sep 6, 2024 03:32 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Price, Consensus and EPS Surprise
LSAK 4.63 +0.11(2.50%)
Will LSAK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LSAK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LSAK
UiPath (PATH) Q2 Earnings and Revenues Top Estimates
Concrete Pumping (BBCP) Misses Q3 Earnings and Revenue Estimates
LSAK: What are Zacks experts saying now?
Zacks Private Portfolio Services
CareMax, Inc. (CMAX) Reports Q2 Loss, Misses Revenue Estimates
Cricut, Inc. (CRCT) Beats Q1 Earnings Estimates
Lesaka Technologies (LSAK) Reports Q2 Loss, Misses Revenue Estimates
Other News for LSAK
Lesaka Technologies Announces Leadership Changes as it Strengthens Executive Management Team
Lesaka CFO Naeem Kola appointed COO, Dan Smith to succeed
Lesaka to Host Webcast and Conference Call to Review Q4 and FY 2024 Results on September 12, 2024
Warning: LSAK is at high risk of performing badly
Warning: LSAK is at high risk of performing badly